scroll down

About Us

Dedicated to the development and innovation in the fields of global molecular imaging technology and contrast agents.

Nanjing Nuoyuan Medical Device Co., Ltd. is a technology-driven enterprise that integrates the R&D, production, and sales of high-end medical equipment and innovative targeted contrast agents, demonstrating continuous innovation capabilities. The company has established an innovative model that combines pharmaceuticals and medical devices, focusing on providing comprehensive, end-to-end solutions for precision diagnosis and treatment of tumors. With a strong focus on core technologies such as molecular fluorescence, Raman spectroscopy, COMS imaging systems, microwave ablation, artificial intelligence in medical imaging and diagnostics, as well as AIDD and CADD, the company offers a wide range of tumor diagnostic and therapeutic devices and fluorescent contrast agents like ICG. It also owns proprietary core technology intellectual property rights and has been granted 188 patents, including 145 Chinese invention patents, 8 U.S. invention patents, 2 European invention patents, and 1 Japanese invention patent.

Focus on providing end-to-end solutions for precision diagnosis and treatment of tumors.

Focus on core technologies including molecular fluorescence, Raman spectroscopy, COMS camera systems, artificial intelligence in medical imaging and diagnostics, as well as AIDD and CADD.

Medicine

Equipment

ODM/OEM

Star Product

Dedicated to the development and innovation in the fields of global molecular imaging technology and contrast agents.

Aishiji – Indocyanine Green (ICG) for Injection

3D4K Endoscopic Fluorescence Imaging System

4K Endoscopic Fluorescence Imaging System

Why Choose Us?

We specialize in providing end-to-end solutions for precision oncology diagnosis and treatment, focusing on core technologies such as molecular fluorescence, Raman spectroscopy, COMS camera systems, artificial intelligence in medical imaging and diagnostics, as well as AIDD and CADD. We offer multiple series of tumor diagnosis and treatment devices (ICG) and have developed a comprehensive product pipeline.

Technical Patent

We have been granted 188 patents, including 145 Chinese invention patents, 8 U.S. invention patents, 2 European invention patents, and 1 Japanese invention patent.

U.S. Invention US12275743B2 - Patent Certificate

U.S. Invention US10948345B2 – Patent Certificate

U.S. Invention US11050951B2 – Patent Certificate

U.S. Invention US11612656B2 – Patent Certificate

U.S. Invention US11718625B2 – Patent Certificate

U.S. Invention US12013286B2 – Patent Certificate

U.S. Invention US12264966B2 – Patent Certificate

U.S. Invention US12433961B2 – Patent Certificate

European Invention EP4015518B1 - Patent Certificate

European Invention EP4183791 - Patent Certificate

Japanese Invention JP7308366B2 - Patent Certificate

Scope of Business

Ministry of Natural Resources Supervision [Review Number: GS(2016)1561]

Jiangsu, Hunan, Sichuan, Hebei, Shanghai, Anhui, Chongqing, Shandong, Shaanxi, Guangdong, Zhejiang, Beijing, Henan, Jilin, Hubei, Yunnan, Heilongjiang, Jiangxi, Fujian, Tibet

China

Pacific Rim

India

Saudi Arabia

Middle East

Peru

Colombia

Brazil

Singapore

Mexico

Costa Rica

Indonesia

Japan

Germany

Russia

United States

South America

China

Pacific Rim

India

Saudi Arabia

Middle East

Peru

Colombia

Brazil

Singapore

Mexico

Costa Rica

Indonesia

Japan

Germany

Russia

United States

South America

Exhibition Information

2025.07.15

[Good News] Nuoyuan Medical: Its 4K Endoscopic Fluorescence Imaging System Receives EU MDR Certification, Further Accelerating Its Internationalization Strategy.

Recently, Nuoyuan Medical’s core product—the 4K endoscopic fluorescence imaging system—successfully obtained certification under the European Union’s new Medical Device Regulation (MDR). This milestone signifies that Nuoyuan Medical has earned international recognition for its product quality and technological strength, injecting strong momentum into the company’s global expansion!

View details →

2024.12.23

[Good News] Combining Pharmaceuticals and Medical Devices for Collaborative Innovation | Class 1 New Drug Petai Jinglv Has Received FDA IND Approval

Paitai Jinglv, a Class 1 new drug independently developed by Nuoyuan Medical, received Investigational New Drug (IND) approval from the U.S. Food and Drug Administration (FDA) on December 20, 2024! This milestone achievement is yet another testament to the company’s core R&D team’s profound expertise and relentless efforts in the biopharmaceutical field. It also marks the first IND approval for a folate-receptor-targeted contrast agent in China, following the successful FDA approval and market launch of Cytalux (OTL-38), the world’s first folate-receptor-targeted imaging agent. This breakthrough underscores China’s significant progress in this field. Paitai Jinglv has already been granted invention patents in China, the United States, Europe, and Japan, highlighting its global innovative strength.

View details →

2024.08.29

[Good News] Nuoyuan Medical has been awarded the Sullivan GIL: Global Leader in R&D of Targeted Molecular Fluorescent Tracers.

From August 28 to 30, 2024, the 18th Sullivan China Growth, Innovation & Leadership Summit and the 3rd New Investment Conference were held in Shanghai. This year’s conference is themed “Unite New Forces, Achieve Quality-Driven Future,” aiming to bring together the wisdom and strength of global industry leaders, academics, research institutions, investors, and media to jointly explore new growth drivers, new markets, and new development paths for China’s economy in the new era.

View details →

[Good News] Nuoyuan Medical: Its 4K Endoscopic Fluorescence Imaging System Receives EU MDR Certification, Further Accelerating Its Internationalization Strategy.

2025.07.15

[Good News] Combining Pharmaceuticals and Medical Devices for Collaborative Innovation | Class 1 New Drug Petai Jinglv Has Received FDA IND Approval

2024.12.23

[Good News] Nuoyuan Medical has been awarded the Sullivan GIL: Global Leader in R&D of Targeted Molecular Fluorescent Tracers.

2024.08.29

The Party Secretary of China Pharmaceutical University Visits Nuoyuan Medical for Research and Investigation.

2023.12.15

[News] Sullivan: Technological Breakthrough and Industry Leadership in China’s Domestic Medical Endoscopes

2023.06.30

Company News

[Good News] Nuoyuan Medical: Its 4K Endoscopic Fluorescence Imaging System Receives EU MDR Certification, Further Accelerating Its Internationalization Strategy.

2025.07.15

[Good News] Combining Pharmaceuticals and Medical Devices for Collaborative Innovation | Class 1 New Drug Petai Jinglv Has Received FDA IND Approval

2024.12.23

[Good News] Nuoyuan Medical has been awarded the Sullivan GIL: Global Leader in R&D of Targeted Molecular Fluorescent Tracers.

2024.08.29

The Party Secretary of China Pharmaceutical University Visits Nuoyuan Medical for Research and Investigation.

2023.12.15

[News] Sullivan: Technological Breakthrough and Industry Leadership in China’s Domestic Medical Endoscopes

2023.06.30

[Good News] Nuoyuan Medical Wins First Prize from the China Invention Association

2022.11.09

Noyuan Medical has successfully been selected as a (first-batch) innovative product of Nanjing City.

2022.09.28

Contact Us

400-999-7198

Headquarters: Building Shengmingyuan, No. 18 Ziyun Avenue, Qinhuai District, Nanjing City

Factory: No. 18, Fuzhian South Road, Nanjing Fourth Bridge Economic Park, Liuhe District, Nanjing City
Email:yangliu@nuoyuanmedical.cn

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

025-88017667

yangliu@nuoyuanmedical.cn